Woodlands Cancer Institute opens three clinic locations that provide medical oncology, radiation oncology and hematology care to its patients.

WOODLANDS, Texas, March 26, 2024 –  American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing networks of independent oncology practices, is pleased to announce the opening of Woodlands Cancer Institute and welcomes its physicians to the network.

Woodlands Cancer Institute is AON’s second practice in Texas and first in Montgomery County. The practice specializes in delivering medical oncology, radiation oncology and hematology care and services in a community-based setting. The practice is led by a team of highly skilled Board-certified medical oncologists and one Board-certified radiation oncologist: Eric P. Kleinbaum, MD; Sandeep “Kodi” Kodityal, MD, FACP; Krishna K. Pachipala, MD, MRCP; and Jason Berilgen, MD.

“We are eager to join AON and look forward to utilizing the resources that are available to us through this new partnership,” said the physician team at Woodlands Cancer Institute. “AON’s vast menu of support and resources provide essential services that are designed to help community-based practices survive and thrive so that there is a continuity of cancer care. These resources are essential to helping us provide comprehensive and high-quality patient care services.”

Through a strategic partnership, AON practices have an immediate connection to important systems and teams that alleviate the administrative burden many independent medical practices encounter when operating a business. Such resources include access to the in-house pathology division, in-house specialty pharmacy for oral oncolytic medication and care coordination team for patient support among other benefits.

“On behalf of AON, I would like to extend a welcome to Woodlands Cancer Institute and their care team to our growing network of oncology practices,” said Anthony Belott, AON’s chief development officer. “Our goal continues to be to deliver the necessary services that allow community practices to thrive so that they can maintain the high quality of patient care they are dedicated to providing within the community. We are excited to be partnering with Woodlands Cancer Institute and the physicians to assist them with their patient care needs and journey to elevating cancer care in their community.”

“Independent medical practices like Woodlands Cancer Institute are critical to closing the cancer care gap by ensuring cancer care and services are accessible at the local level,” said Todd Schonherz, AON’s chief executive officer. “We are honored that Woodlands Cancer Institute has selected AON to partner with and look forward to witnessing their success in serving their patients.”

For more information about AON, visit www.AONcology.com. For more information about Woodlands Cancer Institute, visit www.woodlandscancer.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

About Woodlands Cancer Institute
Woodlands Cancer Institute is a community-based medical oncology, radiation oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, we strive to provide the best possible experience to patients and their families throughout the healthcare journey. Learn more at www.woodlandscancer.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Alti Rahman and Susan Sabo-Wagner were selected as panelists at the Association of Cancer Care Centers event in Washington, D.C.

FORT MYERS, Fla., March 7, 2024 – American Oncology Network (AON) (Nasdaq: AONC) is pleased to announce its leaders who participated in the Association of Cancer Care Centers (ACCC) 50th Annual Meeting & Cancer Center Business Summit. Alti Rahman, MBA, MHA, CSSBB, and Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC, were selected to be session panelists and are active members of the ACCC planning task force for the Summit, and Anne Marie Rainey, AON’s director of value-based care, serves on the ACCC board.

The Summit, held from February 28 to March 1 at Capitol Hill in Washington, D.C., gathered healthcare leaders, health policy experts and key influencers in cancer care delivery for educational and networking opportunities, according to the ACCC event website. The Summit’s purpose was to analyze innovative solutions to cancer care challenges.

Rahman, AON’s chief strategy & innovation officer, participated as a panelist in the sessions “Deep Dive 3: Payer, Manufacturer, and Supply Chain Challenges”; and “Deep Dive 6: Artificial and Business Intelligence Technology.”

Sabo-Wagner, AON’s vice president of clinical innovation, joined Rahman as a panelist in the session “Deep Dive 6: Artificial and Business Intelligence Technology.”

“It is an honor to have been invited to share my expertise and perspective as a panelist at the Annual Meeting & Cancer Center Business Summit,” said Rahman. “The Summit lays the groundwork to dive into pressing issues that face cancer care while exploring innovative solutions to the challenges that face our industry. I enjoyed having the opportunity to engage in dynamic conversations and exchange best practices with fellow panelists and attendees.”

“We are excited to have our leaders serve as panelists of this prestigious event,” said Todd Schonherz, AON’s chief executive officer. “This is a testament to the depth of experience and thought leadership within our organization and illustrates our commitment to driving positive change within the industry. I am confident that our leaders made significant contributions to the discussions and inspired fellow industry peers.”

For more information about AON, visit www.AONcology.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

The community oncology practice is equipped to treat a wide variety of cancer types and is open to both new and current patients.

CUMMING, Ga., February 6, 2024 –  Cancer and Blood Specialists of Georgia, a partner practice of American Oncology Network (AON) (Nasdaq: AONC), announced today the opening of its new clinic in Cumming, which is located at 101 Greenfield Drive, Suite 220.

The clinic is the second location for the practice with the first being established in Johns Creek, which opened to the community in September 2022. The dedicated space is designed to provide cancer care and services in a comfortable and compassionate environment that promotes patient health and wellness.

The clinic is over 4,000 square feet and includes four private exam rooms and nine infusion chairs. Board-certified medical oncologists Sreekanth C. Reddy, MD, and Aneesha Ananthula, MD, along with the practice’s nurse practitioner Meredith Kirk, APRN, will serve patients at the new clinic.

“I am thrilled to announce the expansion of our practice,” said Dr. Reddy. “It has been our honor to serve the patients in Johns Creek, and we are honored to have the opportunity to bring our care to the Cumming community. Our new clinic will provide the critical healthcare services needed to treat various cancer types and be delivered through our holistic and personalized care approach.”

Cancer and Blood Specialists of Georgia is a community-based practice that delivers a variety of cancer services. Through its partnership with AON, the practice is able to provide essential services such as the centralized laboratory and pathology, an in-house specialty pharmacy for oral oncologic prescriptions and a care coordination program as well as financial counseling for patients. The new clinic will continue to provide these comprehensive care services and support that mirrors the patient offerings at Johns Creek.

“No matter where our patients decide to receive care, they will encounter the same experience at both clinics, which is grounded in delivering compassionate cancer care at all times and the patient-first mentality,” said Dr. Reddy. “We look forward to serving this new community.”

“At AON, we are continuously looking for opportunities to help community oncology practices expand so that they can improve access to cancer care,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “We remain firm in our commitment that these necessary healthcare services should be available and accessible to all — no matter the patient’s location. Congratulations to the practice on the new clinic, and we are ready to support the care team as they serve this new community.”

For more information about AON, visit www.AONcology.com. For more information about Cancer and Blood Specialists of Georgia, visit www.cancerbloodspecialistsga.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at www.AONcology.com.

About Cancer and Blood Specialists of Georgia
Specialists in the diagnosis and treatment of cancer and blood disorders, Cancer and Blood Specialists of Georgia providers have been serving patients in Johns Creek, Georgia, and surrounding Atlanta areas for more than 18 years. As a community-based practice, we offer a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at www.cancerbloodspecialistsga.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Mandy Robertson, MD, joins the community oncology practice.

OLYMPIA, Wash., January 29, 2024 – Vista Oncology, a partner practice of American Oncology Network (AON) (Nasdaq: AONC), is pleased to welcome new physician Mandy Robertson, MD, to its care team and is now accepting patients at the Olympia clinic location.

Dr. Robertson is Board-certified in internal medicine, medical oncology and hematology. She received her medical degree from the University of Florida in Gainesville, Florida. She then completed her internal medicine residency at Virginia Medical Center in Seattle, Washington, and a hematology-oncology fellowship at the University of Florida College of Medicine.

“It is a pleasure to be joining the team at Vista Oncology,” said Dr. Robertson. “I have been impressed by the physicians and the level of care provided at the practice. My decision to join the team stems from the shared values of integrity and compassion. My goal is to contribute to the continued success of Vista Oncology, and I am eager to collaborate with my fellow physicians to improve the health of our community and provide care to our patients who have trusted us with their care.”

Dr. Robertson will join Vista Oncology’s other Board-certified physicians: Ahmad Ali Fora, MD; Min S. Kang, MD, MS; Linli Xuan, MD; and Joseph Z. Ye, MD.

“On behalf of the entire team at Vista Oncology, it is my honor to welcome Dr. Robertson to our practice,” said Joseph Z. Ye, MD, medical oncologist at Vista Oncology. “Her passion for patient care and commitment to excellence in cancer care align seamlessly with our values. This is an exciting moment for our practice because we are able to expand our physician team, allowing us to serve more patients, as well as increase our capabilities to continue providing our comprehensive cancer care and therapies.”

“Congratulations to Vista Oncology on expanding their physician team to include Dr. Robertson,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “She brings a wealth of valuable knowledge and experience to the practice. I look forward to witnessing the positive impact she will have on the health and well-being of our patients in the community.”

For more information about AON, visit www.AONcology.com. For more information about Vista Oncology, visit www.vista-oncology.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at www.AONcology.com.

About Vista Oncology
We offer the most comprehensive levels of comfort, care, and compassion. Vista utilizes the most advanced treatments and every available resource, from recent molecular studies to industry-sponsored clinical trials in order to ensure patient-tailored cancer survivorship on every step of the journey. Vista’s partners and care teams are leaders in scientific discovery for the prevention, treatment, and curing of cancer. They include UW Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, and Virginia Mason Medical Center. Our partners and care teams offer cutting-edge care options and nationally recognized research teams. Learn more at www.vista-oncology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

The network’s physicians’ research reports were selected after a thorough peer review process.

FORT MYERS, Fla., December 21, 2023 –  American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing networks of community oncology practices, is pleased to announce its physicians Ruemu E. Birhiray, MD; Ralph V. Boccia, MD, FACP; and Arvind Chaudhry, MD, PhD, were selected to present their research results at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, California, which was held on December 9 through December 12.

Each year, over 5,000 scientific abstracts undergo a meticulous and thorough peer review process, with only a select few earning acceptances for oral and poster presentations at the annual meeting and exposition. The selected abstracts epitomize crucial and innovative research in the field.

The following AON physician investigators presented their research results during poster discussions and presentations at the annual meeting:

• Dr. Ruemu E. Birhiray, Board-certified medical oncologist at Hematology Oncology of Indiana, authored two reports: “Clinical Research in the Community” and “DEI in Clinical Trials: Where Are We Now and Where We Should Strive to be.” Dr. Birhiray also served as moderator of the session “Setting Realistic Goals for DEI in Hematology Trials.”
• Dr. Ralph V. Boccia, Board-certified medical oncologist at The Center for Cancer and Blood Disorders, served as coauthor of several reports: “Brentuximab Vedotin in Frontline Therapy of Hodgkin Lymphoma in Patients with Significant Comorbidities Ineligible for Standard Chemotherapy (SGN35-015 Part E),” “A Phase 1 Trial Evaluating the Addition of Lenalidomide to Relapsed/Refractory Multiple Myeloma Patients Progressing on Ruxolitinib and Methylprednisolone,” “Multiple Myeloma: Prospective Therapeutic Trials: Poster III,” and “Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Poster III.”
• Dr. Arvind Chaudhry, Board-certified medical oncologist at Summit Cancer Centers, served as coauthor of one report: “Bellwave-010: Phase 3, Open-Label, Randomized Study of Nemtabrutinib Plus Venetoclax Versus Venetoclax Plus Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following at Least One Prior Therapy.”

“Having the opportunity to share and present your research at the annual meeting is a proud accomplishment,” said Dr. Boccia, who also serves as AON Research Committee Chairman. “As physicians, we are on the front lines of patient care, and our research is an extension of that commitment. This platform highlights the alignment between medical inquiry and improved patient outcomes, emphasizing the imperative for physicians to actively contribute to the continuous advancements of medical knowledge. Let this moment energize us to persist in our pursuit of medical knowledge that contributes meaningfully to the well-being of those we serve.”

“It is with immense pride and honor that I acknowledge the physicians in our network who have been selected to share their research reports with colleagues from across the nation,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Their commitment to research and the betterment of patient care is a testament to the caliber of physicians we have at AON. I am grateful to be a part of a network of physicians who are advancing healthcare through research and are pushing the boundaries of healthcare innovation to improve patient outcomes.”

According to the ASH website, the in-person and virtual annual meeting and exposition brought together medical professionals who specialize in hematology care for four days of immersive learning, networking, and knowledge-sharing opportunities. It featured the latest educational and scientific content in hematology, designed to help attendees learn from the top minds in the field.

For more information about AON, visit www.AONcology.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com